Dawn Parsell Otto - 31 Dec 2021 Form 4 Insider Report for Tricida, Inc.

Role
EVP, Clinical Development
Signature
/s/ Geoffrey M. Parker, attorney-in-fact
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
-$15,047
Form type
4
Filing time
04 Jan 2022, 15:20:22 UTC
Previous filing
11 Jun 2021
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCDA Common Stock Tax liability $15,047 -1,574 -31% $9.56* 3,465 31 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs granted on September 10, 2020.
F2 This amount includes 402 shares acquired on December 31, 2020 under the Tricida, Inc. 2018 Employee Stock Purchase Plan. These acquisitions are exempt from Section 16(b) pursuant to Rule 16b-3(c) and exempt from Section 16(a) pursuant to Rule 16a-3(f)(1)(i)(B).